Dobutamine: Too dangerous for "routine" administration?

Anesthesiology

Volumn 108, Issue 6, 2008, Pages 973-974

  Butterworth, John ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMRINONE; DOBUTAMINE; INOTROPIC AGENT; MILRINONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARDIOTONIC AGENT;

ACUTE HEART FAILURE; CLINICAL PRACTICE; CORONARY ARTERY BYPASS SURGERY; DRUG INDICATION; EDITORIAL; HUMAN; MEDICAL DECISION MAKING; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; ROUTINE ADMINISTRATION; TACHYCARDIA; CORONARY ARTERY BYPASS GRAFT; NOTE; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; RISK FACTOR;

ADRENERGIC BETA-AGONISTS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; DOBUTAMINE; HUMANS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 45149124529     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318172fb98     Document Type: Editorial

References (15)

1. Royster RL, Butterworth JF IV, Prough DS, Johnston WE, Thomas JL, Hogan PE, Case LD, Gravlee GP: Preoperative and intraoperative predictors of inotropic support and long-term outcome in patients having coronary artery bypass graft- ing. Anesth Analg 1991; 72:729-736
2. 2. Butterworth JF IV, Legault C, Royster RL, Hammon JW Jr: Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth Analg 1998; 86:461-467 (Pubitemid 28119400)
3. Müller M, Junger A, Bräu M, Kwapisz MM, Schindler E, Aklntürk H, Benson M, Hempelmann G: Incidence and risk calculation of Inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia record-keeping system. Br J Anaesth 2002; 89:398-404
4. 4. Kastrup M, Markewitz A, Spies C, Carl M, Erb J, Grobe J, Schirmer U: Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: Results from a postal survey. Acta Anaesthesiol Scand 2007; 51:347-358 (Pubitemid 46271114)
5. 5. De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ: The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007; 104:766-773 (Pubitemid 46548294)
6. Fellahi J-L, Parlenti J-J, Hanouz J-L, Plaud B, Riou bB, Ouattara A: Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: Propensity- adjusted analyses. ANESTHESIOLOGY 2008; 108:979-987
7. 7. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN III, INTrEPID Investigators: Chronic mechanical circulatory support for ino- trope-dependent heart failure patients who are not transplant candidates: Results of the INTrEPID trial. J Am Coll Cardiol 2007; 50:741-747 (Pubitemid 47239315)
8. Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A, European Milri- none Multicenter Trial Group: Comparison of the hemodynamic effects of mil- rinone with dobutamine In patients after cardiac surgery. J Cardiothorac Vase Anesth 2001; 15:306-315
9. 9.MacGregorDA,ButterworthJFIV,ZalogaGP,PrielippRC,JamesR,RoysterRL: Hemodynamicandrenaleffectsofdopexamineand dobutamineInpatientswithreducedcardiac outputfollowingcoronaryarterybypassgrafting.Chest1994;106:835- 841(Pubitemid24278892)
10. Butterworth JF IV, Prielipp RC, Royster RL, Spray BJ, Kon ND, Wallen- haupt SL, Zaloga GP: Dobutamine Increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery. J Cardlothorac Vase Anesth 1992; 6:535-541
11. Rich MW, Woods WL, Davila-Roman VG, Morello PJ, Kurz H, Barbarash R, Spinner L, Sperry J, Beckham V, Coulter L, Brown P: A randomized comparison of Intravenous amrinone versus dobutamine in older patients with decompen- sated congestive heart failure. J Am Geriatr Soc 1995; 43:271-274
12. 12. Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, Ross J Jr: Influence of heart rate on mortality after acute myocardial Infarction. Am J Cardiol 1990; 65:547-553 (Pubitemid 20091878)
13. Butterworth JF IV, Zaloga GP, Prielipp RC, Tucker WY Jr, Royster RL: Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone. Chest 1992; 101:174-180
14. Prielipp RC, MacGregor DA, Royster RL, Kon ND, Hines MH, Butterworth JF: Dobutamine antagonizes epinephrine's biochemical and cardiotonic effects: Results of an in vitro model using human lymphocytes and a clinical study in patients recovering from cardiac surgery. ANESTHESIOLOGY 1998; 89:49-57
15. Leineweber K, Bogedaln P, Wolf C, Wagner S, Weber M, Jakob HG, Heusch G, Philipp T, Brodde OE: In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism. Naunyn Schmiedebergs Arch Pharmacol 2007; 375:303-309